Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin).
作者信息
MONTGOMERY D B, OGRYZLO M A
出版信息
Can Med Assoc J. 1960 Oct 22;83(17):885-8.
Abstract
摘要
相似文献
1
Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin).
Can Med Assoc J. 1960 Oct 22;83(17):885-8.
2
Benemid, flexin and anturane as uricosuric agents.
Conn Med. 1962 Sep;26:561-2.
3
Zoxazolamine as a uricosuric agent. I. Acute effects in healthy non-ghouty subjects.
Arthritis Rheum. 1961 Oct;4:533-51. doi: 10.1002/art.1780040509.
4
THE TREATMENT OF GOUT.
N Z Med J. 1964 Sep;63:567-74.
5
Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
Arch Farmacol Toxicol. 1975 Mar;1(1):43-6.
6
A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671.
J Pharmacol Exp Ther. 1957 Mar;119(3):418-26.
7
Long term uricosuric therapy in gout.
Arthritis Rheum. 1962 Aug;5:384-96. doi: 10.1002/art.1780050406.
8
[Experiences with gout, especially with uricosuric therapy using anturan].
Z Rheumaforsch. 1962 Feb;21:42-50.
9
[A saluretic active component of the uricosuric G-28315 (anturan)].
Med Exp Int J Exp Med. 1959;1:344-7.
10
Urate excretion.
Annu Rev Med. 1977;28:349-54. doi: 10.1146/annurev.me.28.020177.002025.
本文引用的文献
1
Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects.
Arthritis Rheum. 1958 Dec;1(6):532-43. doi: 10.1002/art.1780010606.
2
Value of uricosuric agents and in particular of G. 28 315 in gout.
Ann Rheum Dis. 1958 Sep;17(3):326-33. doi: 10.1136/ard.17.3.326.
3
Zoxazolamine -- a potent uricosuric agent; preliminary report.
N Engl J Med. 1958 May 1;258(18):894-6. doi: 10.1056/NEJM195805012581808.
4
Evaluation of uricosuric agents in chronic gout.
Ann Rheum Dis. 1957 Dec;16(4):425-37. doi: 10.1136/ard.16.4.425.
5
Management of gout.
N Engl J Med. 1957 Jan 31;256(5):214-9; concl. doi: 10.1056/NEJM195701312560505.
6
Clinical experience with a new muscle relaxant, zoxazolamine; preliminary report.
J Am Med Assoc. 1956 Mar 3;160(9):742-5. doi: 10.1001/jama.1956.02960440014004.
7
Gout--now amenable to control.
Ann Intern Med. 1955 Jan;42(1):1-10. doi: 10.7326/0003-4819-42-1-1.
8
Sodium salicylate and probenecid in the treatment of chronic gout; assessment of their relative effects in lowering serum uric acid levels.
Ann Rheum Dis. 1954 Sep;13(3):233-45. doi: 10.1136/ard.13.3.233.
Zotero 插件